Zealand Pharma A/S ZEALAND PHARMA AKTIESELSKABET ORD SHS
Zealand Pharma A/S ZEALAND PHARMA.../ DK0060257814 /
0NZU
|
15.11.2024 18:33:30
|
Изменение
-42.17
|
Объем сделки |
Бид15.11.2024 |
Предложение15.11.2024 |
Максимум |
Минимум |
|
759.33DKK
|
-5.26%
|
5,691
Оборот: 4.24 млн |
-Величина цены спроса: - |
-Величина цены предложения: - |
784.00 |
717.50 |
Описание деятельности
Zealand Pharma A/S is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products.
Правление & Наблюдательный совет
| Исполнительный директор |
| Adam Steensberg |
| Правление |
| Henriette Wennicke, David Kendall, Ivan Møller, Christina Sonnenborg Bredal , Ravinder Chahil |
| Наблюдательный совет |
| Martin Nicklasson, Kirsten A. Drejer, Jeffrey Berkowitz, Bernadette Connaughton, Leonard Kruimer, Alain Munoz, Michael John Owen, Frederik Barfoed Beck, Anneline Nansen, Louise Gjelstrup, Jens Peter Stenvang, Enrique Conterno, Elaine Sullivan |
Данные компании
| Имя: |
Zealand Pharma A/S |
| Адрес: |
Sydmarken 11,2860 Søborg |
| Телефон: |
- |
| Факс: |
- |
| E-mail: |
+45 88 77 36 00
|
| Интернет: |
info@zealandpharma.com |
| Индустрия: |
Biotechnology |
| Сектор: |
Biotechnology |
| Подсектор: |
- |
| Конец финансового года: |
31.12 |
| Акции в свободном обращении: |
- |
| Дата IPO: |
- |
